$50 BILLION DOLLARS. Gone. In a single trading session.
Yesterday, Novo Nordisk—the company behind Ozempic and Wegovy, the company that basically invented the weight loss drug revolution—watched 18% of its market value disappear in hours.
But here's what makes this story wild. After the crash, their new CEO got in front of investors and said: "People should expect that it goes down before it comes back up."
He told them it gets worse from here.
Today's Show:
- The Crash: $50B wiped out, 18% drop, guidance 10x worse than expected
- The Trump Factor: TrumpRx forced an 85% price cut on Wegovy
- The Competition: Eli Lilly's next-gen drug showing 28.7% weight loss
- The Knockoffs: Compounding pharmacies selling semaglutide for $200 vs $1,000
- The Leadership Shakeup: New CEO, US chief leaving, former CEO back as chairman
- The Denmark Problem: One company = 40% of the Copenhagen Stock Exchange
- Bull vs Bear Case: Volume play or falling knife?
Key Numbers:
- Stock drop: 18% in one day
- 2025 performance: Down 50%
- Guidance: Sales DOWN 5-13% (analysts expected -1.4%)
- Wegovy pill signups: 170,000 in first 4 weeks
- Price cut: $1,000/month → $149/month (85% reduction)
- Eli Lilly next-gen results: 28.7% average weight loss
Sources Referenced:
- CNBC: Novo Nordisk Stock Crashes on 2026 Guidance
- Reuters: Novo Nordisk Issues Bleak 2026 Forecast
- Reuters: Trump Obesity Drug Deal with Novo and Lilly
- Reuters: Lilly's Next-Gen Drug Tops Zepbound in Trials
- Yahoo Finance: Novo Nordisk Shares Tumble 18%
- Euronews: Novo Nordisk Stock Sinks After Bleak Forecast
CEO Quotes (Mike Doustdar):
- "People should expect that it goes down before it comes back up"
- "No matter how well the pill does, the price hit on the existing business trumps the great pill launch"
- "We are creating affordability for millions of patients who simply could not afford it"
Chapters:
- 00:00 - The $50 Billion Crash
- 01:15 - What Is Novo Nordisk?
- 02:30 - The Catastrophic 2026 Guidance
- 03:45 - CEO Says "It Gets Worse"
- 05:00 - The Trump Factor: 85% Price Cut
- 06:30 - Eli Lilly Is Winning
- 08:00 - Compounding Pharmacies
- 09:00 - Leadership Shakeup
- 10:00 - The Denmark Problem
- 11:00 - What Analysts Are Saying
- 12:00 - Bull Case vs Bear Case
- 14:30 - What To Watch
- 15:45 - Final Thoughts
Follow the Show:
Website: moneymen.fm
Tools We Use:
→ TradingView: Get TradingView (Charts & analysis)
Some links above support the show at no extra cost to you.
- (00:00) - The $50 Billion Crash
(01:15) - What Is Novo Nordisk?(02:30) - The Catastrophic 2026 Guidance(03:45) - CEO Says It Gets Worse(05:00) - The Trump Factor: 85% Price Cut(06:30) - Eli Lilly Is Winning(08:00) - Compounding Pharmacies(09:00) - Leadership Shakeup(10:00) - The Denmark Problem(11:00) - What Analysts Are Saying(12:00) - Bull Case vs Bear Case(14:30) - What To Watch(15:45) - Final Thoughts